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Abstract
The national Quality Assurance for Aboriginal Medical Services (QAAMS) Program, in which point-of-care testing (POCT) 
for haemoglobin A
1c
 (HbA
1c
) and urine albumin:creatinine ratio (ACR) is performed for diabetes management in 65 Australian 
Aboriginal medical services, is now embedded in the practice of diabetes care across Indigenous Australia. This paper documents 
the results of a detailed survey to assess levels of satisfaction with the QAAMS HbA
1c
 Program among three key stakeholder 
groups – doctors, POCT operators and patients with diabetes. Both doctors and patients with diabetes agreed that the immediacy 
of POCT results contributed positively to patient care, improved the doctor-patient relationship, and made the patient more 
likely to be both compliant and self-motivated to improve their diabetes control. Both POCT operators and patients with diabetes 
reported improved satisfaction with their diabetes services after the introduction of POCT. The paper also provides evidence 
from two participating medical services that POCT has been an effective tool in improving the delivery of pathology services 
and clinical outcomes for both individuals and groups of patients with diabetes. A statistically signiﬁ cant reduction in HbA
1c
 from 
9.3% (± 2.0) to 8.6% (± 2.0) was observed in 74 diabetes patients 12 months after commencing POCT (p = 0.003, paired t-test). 
An improvement in the percentage of patients achieving glycaemic targets and a reduction in the percentage of patients with poor 
control was also observed in this group. These data provide evidence that the QAAMS POCT model delivers a culturally and 
clinically effective service for diabetes management in Aboriginal Australia.
Introduction
Type 2 diabetes mellitus and its principal complications, 
renal disease and retinopathy, are responsible for a signiﬁ cant 
burden of morbidity, mortality, social and cultural trauma in 
Australia’s Aboriginal people.1-3 In 1998, Australia’s National 
Diabetes Strategy and Implementation Plan recommended that 
a trial of POCT for HbA
1c
 on the DCA 2000 analyser (Bayer 
Diagnostics, Tarrytown, NY, USA) be conducted in Australian 
Aboriginal Medical Services to assist diabetes management 
for Indigenous people.4 The resultant QAAMS Program for 
HbA
1c
 POCT commenced as a pilot in 45 Aboriginal Medical 
Services in June 1999. Six years later, the national QAAMS 
Program has 65 participating medical services, 75% of which 
are located in rural and remote Australia. The program has 
now become ﬁ rmly embedded in the practice of diabetes 
care for Aboriginal people.5-7 In 2003, the program was 
expanded to include urine ACR POCT on the DCA 2000 to 
monitor microalbuminuria in Aboriginal diabetes patients.8 
The QAAMS Program has been continuously funded by the 
Australian Government’s Department of Health and Ageing 
since its inception.
The QAAMS model provides continuing education, training, 
competency assessment and support services for Aboriginal 
health workers and allied health professionals in their role as 
in-service POCT operators. The program also has a unique 
quality management framework involving both internal 
quality control and external quality assurance testing. These 
features set QAAMS apart from any other model of primary 
health care delivery for Indigenous communities world-
wide. The ability of Aboriginal health workers to conduct 
POCT in the ﬁ eld to an analytical standard that meets current 
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laboratory-based goals has been veriﬁ ed for both HbA
1c
 and, 
more recently, urine ACR testing.5-6,8
However, two key research questions for the QAAMS Program 
remained unanswered. Firstly, how well had the program 
been accepted by clinical staff (utilising POCT results for 
patient management), by Aboriginal health workers and allied 
health professional staff (as POCT ﬁ eld operators) and by 
patients with diabetes (the consumers of the POCT service)? 
Secondly, had POCT been an effective tool in improving 
clinical outcomes for both individuals and groups of patients 
with diabetes?
This paper provides the evidence base to answer these 
questions. It documents the results of a detailed questionnaire 
to assess levels of acceptance with the QAAMS HbA
1c
Program among its three key stakeholder groups – doctors, 
POCT operators and patients with diabetes. The paper also 
reports improvements in glycaemic control among diabetes 
patients at two rural and remote Aboriginal medical services in 
the QAAMS Program following the introduction of POCT.  
Methods
Questionnaire for Key Stakeholders in the QAAMS Program
During mid-2004 the QAAMS Program Manager, in 
collaboration with the Flinders University Centre for 
Biostatistics and Epidemiology, prepared three questionnaires 
for dissemination to all Aboriginal medical services 
participating in the QAAMS Program. A small group of 
Aboriginal health workers from selected medical services 
assessed the questionnaires for their cultural appropriateness 
in their development phase. 
The questionnaires were speciﬁ cally designed to determine 
satisfaction levels with the QAAMS HbA
1c
 Program among 
three key stakeholder groups; namely doctors, Aboriginal 
health workers and allied health professionals, and patients 
with established diabetes.
Each questionnaire contained a series of short statements or 
questions, with respondents rating their level of agreement or 
disagreement with the statement or question posed according 
to a ﬁ ve-point Likert scale.9 Participants were given equal 
opportunity to agree or disagree with each statement or 
question. The questionnaire also listed other open questions 
where a more detailed written response was requested or 
selections could be made from a series of options provided. 
In relation to the patient questionnaire, Aboriginal health 
workers were invited to work with and assist as many 
diabetes patients as possible to complete this questionnaire. 
All respondents completed the questionnaires anonymously. 
Distribution of the questionnaires commenced in mid-July 
2004. The Chief Executive Ofﬁ cer of each Aboriginal medical 
service was also sent an accompanying letter, explaining the 
purpose of the questionnaires. Services were asked to return 
their completed questionnaires by fax or post by mid-October 
2004.  
The results of the questionnaires were analysed by the QAAMS 
Program Manager, in collaboration with an epidemiologist (Dr 
Kristin McLaughlin) from the Flinders Centre for Biostatistics 
and Epidemiology using the Epidata software program (www.
epidata.dk).
Impact of POCT on Delivery of Pathology Services and 
Clinical Outcomes
For the past two years, the QAAMS Program Manager and 
his supporting scientiﬁ c team have worked closely with two 
Aboriginal health services in rural and remote Australia to 
collect information concerning the impact of POCT on the 
delivery of pathology services and on clinical outcomes 
among individuals and groups of patients with diabetes. 
These studies have been conducted at the request of the 
health services concerned and have been undertaken since 
full DCA 2000 POCT services for diabetes management were 
introduced at each site.
Information was initially obtained on the number of HbA
1c
test requests from patients with diabetes who attended their 
clinics for set periods immediately preceding and following 
the introduction of POCT; these periods were one year for 
service 1 and two years for service 2, respectively.
POCT HbA
1c
 results on patients with diabetes who attended 
the clinics at both services were monitored across a 12-month 
period to assess the change in glycaemic control following the 
introduction of POCT. All POCT HbA
1c
 tests were performed 
on-site by the principal Aboriginal POCT operator at each 
site. 
Results
Questionnaire for Key Stakeholders in the QAAMS Program
(i) Questionnaire for Doctors
41 doctors completed the clinician questionnaire. A summary 
of their responses is shown in Table 1. Greater than 95% of 
doctors agreed that POCT provided a convenient service for 
them. Approximately 90% felt conﬁ dent with the accuracy 
and reliability of the POCT result and that POCT was an 
acceptable alternative to the laboratory. More than 90% 
of doctors stated that the immediacy of the POCT result 
contributed positively to patient care, they were comfortable 
in continuing to use POCT for patient management, and they 
would like to see POCT available to all patients with diabetes 
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in their community. More than 80% of doctors agreed that 
POCT provided a more culturally and clinically effective 
service for the patient than their laboratory service and that 
POCT contributed positively to their rapport and relationship 
with their patients. Over 60% of the doctors felt that patients 
were more likely to return for a follow-up visit, with more than 
half believing the immediate availability of results contributed 
positively to patient compliance with medication.
One doctor responded negatively to all questions asked. This 
doctor preferred to use the local laboratory service, ordering 
a complete proﬁ le of tests for diabetes management on every 
patient. The Aboriginal health workers at this site remained 
keen to use the DCA 2000 but had been progressively 
discouraged to do so by the doctor.
Selected written comments received from doctors are listed 
below in response to the question: How did you view the 
clinical effectiveness of the DCA 2000 point-of-care testing 
program overall and (could you comment on) whether it 
had contributed to improved diabetes management in your 
service? These comments are reﬂ ective of the overall views 
of the 23 doctors who responded to this question.
‘This has made a well run Diabetic Clinic to be 
more effective and impressive to the patient; most 
of the aboriginal patients are reluctant to come 
back in a few days for their results. Thus, a well-
run point of care test facility gives me a chance to 
have a bird’s eye view of where a patient stands 
and helps me to readjust their regime.’
‘The DCA 2000 POC test adds greatly to the 
assessment and management of diabetics in our 
practice by giving a ‘real time’ picture of the 
progress, especially after changes have been made 
to their management. It enhances doctor/diabetic 
team AND patient satisfaction and most certainly 
imparts positively on patient outcomes.’
‘Many clients of this service do not come for 
follow-up appointments and so it is very beneﬁ cial 
to have the POC HbA
1c
 result available at the time 
of that visit rather than hoping they will return. 
Treatment decisions about need for medication 
change or need for further diabetic education, 
weight loss, or diet, etc., can all be made at the 
one visit.  This greatly improves patient care and 
Clin Biochem Rev Vol 27 August 2006  I  163
QAAMS POCT 
Table 1. Results of satisfaction questionnaire for doctors (n=41)
                                        DISAGREE UNSURE AGREE
                       Synopsis of Statement Strongly Disagree Agree or
  or Disagree Strongly Agree
  n % n % n %
Section 1. Speciﬁ c Questions
Convenience
Satisﬁ ed with POCT results immediately available  1 2% 1 2% 39 96%
Advantage discussing results immediately with patient  1 2% 0 0% 40 98%
Analytical Quality
Conﬁ dent in accuracy and reliability of POCT result  1 2% 4 10% 36 88%
POCT acceptable alternative to laboratory  2 5% 2 5% 37 90% 
Patient Care Issues
Immediate result contributes positively to patient care  1  2% 1 2% 39 96%
Immediate result contributes positively to patient compliance 2 5% 17 41% 22 54%
Immediate result contributes positively to relationship with patient 2 5% 5 12% 34 83%
Patient more likely to return if POCT available  2 5% 14 34% 25 61%
POC HbA
1c
 testing made positive contribution to patient management 1 2% 1 2% 39 96%
Like POCT for HbA
1c
 to continue for diabetes management 1 2% 0 0% 40 98%
General Issues
Like to see POCT for HbA
1c
available for all diabetics in the community 1 2% 3 7% 37 91%
POCT for HbA
1c
 more clinically and culturally effective than laboratory 2 5% 4 10% 34 85%
the likelihood of reducing long-term diabetic 
complications.’
‘The advantages of having this POC testing 
are incalculable. There are many patients we 
would otherwise not be able to follow-up or 
treat appropriately. This is because they are often 
travelling, they have some reluctance to go to 
pathology dep[artmen]t. within the hospital, or 
they do not understand the risks associated with 
their illness.’
‘HbA
1c
 testing was poorly taken up prior to the 
POC program. Seeking out people for urine testing 
was even harder. Now that we can give immediate 
results and discuss them straight away, clients 
are happy. They are even happier that the AHWs 
[Aboriginal health workers] are doing all this. We 
now are collecting consistent longitudinal data.’
(ii) Questionnaire for POCT Operators (Aboriginal health 
workers and allied health professionals)
65 respondents completed this questionnaire. Of the 61 who 
speciﬁ ed their health profession, 51% were Aboriginal health 
workers and 41% were nurses; the remaining respondents were 
diabetes educators (2), a community health worker (1) and a 
primary health care network co-ordinator (1). A summary of 
their responses is shown in Table 2. 
Greater than 90% of POCT operators agreed that the QAAMS 
educational resources were culturally appropriate, and they 
understood why the HbA
1c
 test needed to be performed on 
patients with diabetes and what the result meant in terms 
of diabetes control. Greater than 90% of respondents were 
conﬁ dent in using the DCA 2000, in the accuracy and 
reliability of the POCT result, and in discussing the result 
with their patients. POC HbA
1c
 testing on a ﬁ nger-prick 
sample was considered an acceptable alternative to laboratory 
testing on a venous sample. Greater than 90% of respondents 
understood the need to perform quality assurance testing and 
felt the frequency of this testing (two samples per month) was 
appropriate. They also felt the level of support and the training 
methods of the QAAMS management team were culturally 
appropriate. 
POCT operators agreed that patients were comfortable in 
having POC HbA
1c
 testing performed as part of their diabetes 
management. Overall community acceptance of POCT was 
high, with approximately 80% of POCT operators agreeing 
that POCT on the DCA 2000 had provided a focus for raising 
community awareness about diabetes and had enhanced 
community ownership. 
POCT operators were also asked to rate how satisﬁ ed they 
were with the diabetes services for their patients before and 
after the introduction of POC HbA
1c
 testing on the DCA 
2000. Figure 1 shows the satisfaction rating of the 57 POCT 
operators who responded to this question. The percentage of 
POCT operators who were unsatisﬁ ed with, or unsure about, 
their diabetes service fell from 30% to 4% and 28% to 7% after 
the introduction of POCT respectively, while the percentage 
who were satisﬁ ed with their diabetes service increased from 
42% to 90% after POCT was introduced (Fishers Exact chi-
square = 4.12, p = 0.271). While this result is not statistically 
signiﬁ cant due to the small sample size, the improvement in 
satisfaction rating with diabetes services since the QAAMS 
Program commenced is clearly evident.   
Figure 1. POCT operator satisfaction with services for 
managing patients with diabetes before and after the 
introduction of POCT (n=57). 
When asked in a series of open questions what the QAAMS 
Program had meant to them personally, over 90% of POCT 
operators stated that it had enabled them to know their 
community members with diabetes better and had given them 
a greater role in their management, while over 70% indicated 
it had provided them with a sense of empowerment and had 
made them better known in their community. 
When asked to specify in what ways their diabetes services 
had improved following the introduction of POCT, over 95% 
of POCT operators stated that POCT was more convenient 
than the laboratory service, with patients having their POC test 
and seeing the doctor during the one visit. 85% of respondents 
felt POCT had improved patient self-motivation.
POCT operators were also asked to comment on what were 
the main issues in maintaining the QAAMS Program in the 
long-term. Over two-thirds felt that neither their current 
workload nor the number of programs they were responsible 
for would preclude them from maintaining participation in 
QAAMS. Nearly three-quarters of respondents felt their 
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Before POCT
After POCT
Satisfaction Rating
P
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  Unsatisﬁ ed                   Unsure                       Satisﬁ ed
Chi-square (Fishers Exact) = 4.12, p = 0.271
current fridge space was adequate to store program reagents 
and consumables. Respondents were unanimous in rating 
the mechanical reliability of the DCA 2000 as good or very 
good. 
POCT operators were invited to provide written comment on: 
‘What are the ‘Positives’ and ‘Negatives’ about the QAAMS 
Program, and how could the program be improved and made 
more effective?’ A list of selected comments, reﬂ ective of the 
overall views of this group, is listed below. 
‘It is very useful to use opportunistically with 
clients who are difﬁ cult with attending follow-ups 
on their health care.’
‘Clients are very happy with it saving them a trip 
to local hospital for blood testing. Clients like 
to know the result, and what it means.
Gives me a chance to continue diabetic 
education.’
‘Well accepted by our health workers and clients 
and CEO. Visiting specialists, podiatrist know 
about the DCA machine. Great asset.’
‘The POC testing has greatly improved service 
delivery particularly with patients who are mobile 
and are not continuously contactable.’
‘Effective POC, mildly invasive, results in 6-7 
minutes instead of 48 hours to 1 week.’
‘The DCA 2000 has given me a time saver in 
showing community how their diabetes is really 
going as they can see the results in 6 min and this 
helps us both to work to a health plan to improve 
the next reading.’
(iii) Questionnaire for Aboriginal Patients with Diabetes
161 clients with diabetes completed this questionnaire, with 
the support and assistance of their local Aboriginal health 
workers. Of the 148 who speciﬁ ed their gender, 58% were 
females and 42% males. Of the 159 who reported their age, 
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Table 2. Results of satisfaction questionnaire for POCT operators (Aboriginal health workers and allied health professionals) 
(n=65)
                                        DISAGREE UNSURE AGREE
                       Synopsis of Statement Strongly Disagree Agree or
  or Disagree Strongly Agree
  n % n % n %
Educational Resources 
Useful and culturally appropriate  0 0% 4 6% 60 94%
Clearly show why POC HbA
1c
 test is needed  0 0% 3 5% 61 95%
Clearly show what POCT result for HbA
1c
 means   2 3% 3 5% 59 92%
DCA 2000 and Testing Procedure   
Conﬁ dent and comfortable using DCA 2000  2 3% 1 2% 62 95%
Fingerprick blood as reliable as venepuncture for  HbA
1c
  0 0% 4 6% 60 94%
Point-of-Care Results
Conﬁ dence in accuracy and reliability  1 2% 0 0% 62 98%
POCT for HbA
1c
 on DCA 2000 acceptable alternative to lab 0 0% 2 3% 61 97%
Conﬁ dent to discuss results with client  3 5% 2 3% 58 92%
Quality Management  
Understand need for quality assurance testing  0 0% 1 2% 63 98% 
Level of quality assurance testing required is appropriate 1 2% 3 5% 60 94%
QAAMS Team and On-going Support
QAAMS Team provides appropriate support  0 0% 3 5% 60 95%
Training methods instructive and appropriate  0 0% 6 10% 55 90%
Overall Community Acceptance
Clients happy with POCT for HbA
1c
 testing   0 0% 1 2% 62 98%
POCT for HbA
1c
 raised awareness about diabetes  1 0% 11 17% 52 83%
DCA 2000 has enhanced community ownership and control 1 2% 12 19% 50 79%
6% were 25-34 years old, 15% 35-44 years, 24% 45-54 years, 
28% 55-64 years and 27% were older than 65. 
A summary of their responses is shown in Table 3. Greater 
than 90% of respondents understood the role of  the DCA 2000 
machine in managing their diabetes and were comfortable 
in having their glycaemic control monitored. Patients were 
very satisﬁ ed (97% or greater) with the convenience of POCT 
and believed a ﬁ nger-prick collection was less stressful than 
venipuncture. More than 90% of patients reported regular 
POCT resulted in improved self-motivation to control their 
diabetes and they were comfortable in returning for further 
testing. Over 90% of patients felt the visit to the doctor was 
more useful and the doctor was able to better manage their 
diabetes by having the POCT result available at the time of 
consultation.  
In separate questions, greater than 95% of respondents wanted 
POCT to continue as part of the management of their diabetes 
and stated they would like POCT to be available to all patients 
with diabetes in their community.
Patients were also asked to rate how satisﬁ ed they were with 
the diabetes services offered to them before and after the 
introduction of POC HbA
1c
 testing on the DCA 2000. Figure 2 
shows the satisfaction rating of the 159 patients with diabetes 
who answered this question. The percentage of patients who 
were unsatisﬁ ed with, or unsure about, their diabetes service 
fell from 11% to 3% and 28% to 6% after the introduction of 
POCT, respectively, while the percentage who were satisﬁ ed 
with their diabetes service increased from 61% to 91% after 
POCT was introduced (Fishers Exact chi-square = 12.09, p = 
0.007, signiﬁ cant).
Figure 2. Patient satisfaction with services for managing their 
diabetes before and after the introduction of POCT (n=159). 
Selected written comments by patients with diabetes are listed 
in response to the question: ‘Do you have any other comments 
on whether POCT has helped you look after your diabetes?’ 
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Table 3. Results of satisfaction questionnaire for patients with diabetes (n=161)
                                        DISAGREE UNSURE AGREE
                       Synopsis of Statement Strongly Disagree Agree or
  or Disagree Strongly Agree
  n % n % n %
Understanding of POCT
Understand what POCT machines are used for  0 0% 10 6% 150 94%
Happy to have diabetes checked by POCT rather than lab 0 0% 3 2% 156 98%
Convenience
Happy with immediate POCT result  1 1% 1 1% 158 98%
Immediate result better than having to come back for lab result 0 0% 1 1% 159 99% 
Fingerprick less stressful than venepuncture  1 1% 3 2% 156 97%
Personal Issues
Regular POCT encourages me to look after my health better 1  1% 10 6% 150 93%
Happy for further POCT to be used for my management  2 1% 2 1% 157 98%
Doctor Patient Issues
Visit to doctor more useful because POCT results available 2 1% 9 6% 149 93%
Doctor better able to manage my health by having POCT results
when seeing the doctor  3 2% 5 3% 152 95%
Satisfaction Rating
P
er
ce
nt
ag
e
  Unsatisﬁ ed                   Unsure                       Satisﬁ ed
Before POCT
After POCT
Chi-square (Fishers Exact) = 12.090, p = 0.007
‘This my ﬁ rst time, I’m new about it and I like it. 
Yes!! I really want to put my head down now, take 
good care of myself and manage my health.’
‘I live 30 kms from the service so it’s much better 
for me.’
‘Instant results make management more convenient 
and efﬁ cient.’
‘Yes it has helped me to stay positive and not to 
get too stressed out as I know help is at the door.’
 ‘The health workers explain everything to me and 
are very helpful. I’m very pleased with this set 
up.’
Impact of POCT on Delivery of Pathology Services and 
Clinical Outcomes
At service 1, in the year following the introduction of POCT, 
there was a 76% increase in both the number of HbA
1c
 tests 
performed and the number of diabetes patients being monitored 
for their glycaemic control. Following the introduction of 
POCT at service 2, there was a 91% increase in the number of 
HbA
1c
 tests performed (with an average of 3.7 HbA
1c
 tests per 
patient performed in the two years after POCT compared with 
2.0 HbA
1c
 tests per patient performed in the two years before 
POCT). Across the same period, there was a 3.5-fold increase 
in the number of urine ACR tests performed (with an average 
of 1.8 urine ACR tests per patient performed in the two years 
after POCT compared with 1.1 urine ACR tests per patient 
performed in the two years before POCT). There was also 
a doubling of the number of patients tested for urine ACR. 
Thus, patients with diabetes at this service received closer 
clinical monitoring of their HbA
1c
 and urine ACR levels (and 
hence diabetes management) after the introduction of POCT. 
Did this increased level of POCT testing at these two services 
translate into improved glycaemic control for Aboriginal 
patients with diabetes? A total of 74 patients with diabetes 
were monitored for their HbA
1c
 levels across both services. 
There was a statistically signiﬁ cant reduction of 0.7% HbA
1c
in this group of 74 patients monitored at baseline (when 
POCT commenced) and at 12 months after the introduction 
of POCT respectively (p = 0.003, 2-tailed paired t-test) (Table 
4). This fall in HbA
1c
 indicated that glycaemic control within 
the group had improved post POCT. 
Patients were further categorised into those who achieved 
optimal glycaemic control (HbA
1c
 <7%), controlled glycaemia 
(HbA
1c
 <8%) and exhibited poor glycaemic control (HbA
1c 
>10%) before and after the introduction of POCT. Current 
best practice guidelines for Aboriginal people recommend 
that the optimal glycaemic goal is an HbA
1c
 of <7%; however, 
in acknowledging that this will be extremely difﬁ cult to 
achieve in many Indigenous people with diabetes, they also 
state that an HbA
1c
 of 8% represents a more realistic target for 
this population.1,10 HbA
1c
 concentrations of 7% and 8% have 
been previously recommended by the American Diabetes 
Association (ADA) as the goal for optimal glycaemic 
control and a value at which a change of therapy is indicated 
respectively.11 More recent recommendations by the ADA 
suggest that even more stringent goals (for example, an HbA
1c
as close as possible to 6%) should be considered for individual 
diabetes patients to further reduce risk of complications at 
the possible increased risk of hypoglycaemia.12 The HbA
1c
value of 10% was selected to represent poor control on both 
empirical and practical grounds. As can be seen in Table 4, 
the percentage of diabetes patients who achieved optimal 
glycaemic control increased by 12%, the percentage who 
achieved controlled glycaemia increased by 19%, and the 
percentage exhibiting poor diabetes control fell by 12%. These 
ﬁ ndings also support the trend towards improved glycaemic 
control after the introduction of POCT. 
Examples of some of the improvements in glycaemic control 
observed within individual patients are provided in the 
following brief case histories:
The ﬁ rst case describes a 57-year-old man who was 
diagnosed with diabetes in 1989. He had not been compliant 
in taking his diabetes medication and had a past history of 
heavy alcohol intake. There was a strong family history of 
diabetes. He visited the health service on average once per 
year but generally declined blood testing and follow-up. 
His last laboratory HbA
1c
 was 13.0%. He attended the clinic 
following the introduction of POCT in the service and his 
initial POCT results were HbA
1c
 12.1% and urine ACR 64 
mg/mmol (normal ACR <2.5 mg/mmol). His blood pressure 
was 158/98 mmHg (target for Aboriginal person with diabetes 
130/80 mmHg) and weight was 124 kg. His cholesterol was 
6.9 mmol/L (target for Aboriginal person with diabetes <4.0 
mmol/L), triglyceride 4.2 mmol/L (target <2.0 mmol/L), 
HDL cholesterol 0.7 mmol/L (target >1.0 mmol/L) and LDL 
cholesterol 5.1 mmol/L (target <2.5 mmol/L).10 As a result of 
his poor glycaemic control, he was placed on selected diabetes 
medications and referred for dietician, diabetes educator and 
podiatry review. His HbA
1c
 by POCT was 10.8% at three 
months and 7.6% at 12 months. His lipids had also improved at 
12 months (cholesterol 5.9 mmol/L, triglyceride 2.6 mmol/L,
HDL 1.0 mmol/L and LDL 3.8 mmol/L). His weight fell to 
110 kg and his blood pressure to 140/90 mmHg. This man’s 
conﬁ dence with a local diabetes system was improved 
considerably by having access to immediate results through 
Clin Biochem Rev Vol 27 August 2006  I  167
QAAMS POCT 
POCT. The signiﬁ cant improvement in his HbA
1c
 reﬂ ected 
attention to multiple aspects of his diabetes care.
The second case describes a 53-year-old man who was 
diagnosed with Type 2 diabetes in 1980. In 2001, he was 
found to have peripheral neuropathy and vascular disease. 
His initial POCT investigations revealed an HbA
1c
 of 10.9% 
and a urine ACR of 66 mg/mmol (normal ACR <2.5 mg/
mmol). His weight was 126 kg. His poor glycaemic control 
and macroalbuminuria (ACR >30 mg/mmol) identiﬁ ed by 
POCT were initially managed with oral hypoglycaemic and 
ACE inhibitor medications. With aggressive management 
and regular POCT over the ensuing 18 months, this patient’s 
HbA
1c
 fell from 10.9% to 7.6%, then to 6.7%. His urine ACR 
levels measured by POCT decreased from 66 mg/mmol to 56 
mg/mmol, then to 44 mg/mmol, while his weight was now 
106 kg. This case describes substantial improvements in 
glycaemic control and reductions in albuminuria and weight 
in a patient with diabetes following intensive management 
that included regular POCT.
Discussion
The QAAMS Program for diabetes management has recently 
completed its sixth year of operation. In March 2001, 
the National Aboriginal Community Controlled Health 
Organisation (NACCHO), the peak body representing 
Aboriginal Community Controlled Health Services in 
Australia, released an independent evaluation on the ﬁ rst 18 
months of the QAAMS Program.13 The Executive Summary of 
this report viewed the use of the DCA 2000 POC technology as 
a major opportunity to better care for and manage Aboriginal 
clients with diabetes within the community setting, while the 
ability of the POC device to generate rapid results served as 
a catalyst to enhance patient self-management. The summary 
also concluded that the DCA 2000’s simplicity of use led 
to high levels of acceptance by Aboriginal health workers 
nationally, with nearly two-thirds of services expressing the 
view that it had raised the self-esteem of their health workers. 
It also concluded that the sense of community control was 
enhanced as a result of management of diabetes becoming 
more focused within Aboriginal medical services. 
Three years since this initial evaluation and with the 
approval of the Australian Government’s Department of 
Health and Ageing, a detailed survey of satisfaction levels 
was undertaken among the three key stakeholder groups 
involved in the QAAMS HbA
1c
 Program – doctors, POCT 
operators and patients with diabetes. The results of this survey 
showed conclusively that the aim of the QAAMS Program 
to provide a more timely, efﬁ cient, and practical diabetes 
monitoring service using a quality assured framework has 
been achieved. 
From the clinical viewpoint, doctors were comfortable 
that the POCT result was accurate and reliable. As POCT 
operators, both Aboriginal health workers and nurses felt the 
education, training and quality management framework that 
underpinned the QAAMS Program was culturally appropriate 
and that the DCA 2000 had proven mechanically sound and 
reliable in Aboriginal hands. Aboriginal health workers again 
reported that POCT had provided them with a sense of self-
empowerment, an important cultural beneﬁ t of the program.13
Both POCT operators and patients with diabetes reported 
improved satisfaction with their diabetes services after the 
introduction of POCT, also reﬂ ecting positive acceptance of 
the QAAMS model. Importantly both doctors and patients 
felt the immediacy of the POCT result contributed positively 
to patient care, improved the doctor-patient relationship, and 
made patients more likely to be both compliant and self-
motivated to improve their health.
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Table 4. Improvement in glycaemic control in Aboriginal patients with diabetes 12 months after the introduction of POCT at two 
rural and remote Aboriginal medical services (n=74)
Parameter Baseline POCT 12 Months After POCT
Reduction in HbA
1c
 Mean ± SD Mean ± SD
HbA
1c
 9.3 ± 2.0 8.6 ± 2.0*
% Patients
Achieving optimal glycaemic control (HbA
1c
<7%) 15% 27%
Achieving controlled glycaemia (HbA
1c
<8%) 28% 47%
Exhibiting poor glycaemic control (HbA
1c
>10%) 35% 23%
*The observed reduction in HbA
1c  
of 0.7 was statistically signiﬁ cant (p = 0.003, paired t-test)
From a clinical outcome perspective, an improvement in 
glycaemic control was observed in a group of 74 diabetes 
patients from two Aboriginal medical services with whom 
the QAAMS management team worked closely. The UKPDS 
study has shown that every 1% decline in HbA
1c
 substantially 
reduced the risk of the microvascular complications of 
diabetes, particularly retinopathy and nephropathy.14 Thus the 
statistically signiﬁ cant fall of 0.7% HbA
1c
 observed in diabetes 
patients at these two services, together with the improvement 
in the percentage of patients achieving glycaemic targets and 
the reduction in the percentage of patients with poor control, 
augur well for the longer-term outcomes of the patients. The 
collection of further longitudinal data on these patient groups 
will continue to be important. 
Convenience, acceptability, immediacy of result and 
improved patient outcomes are often quoted with limited 
supporting data as ‘potential’ advantages of POCT. The 
results documented in this paper conﬁ rm, for the ﬁ rst time, 
the widespread acceptance of the QAAMS POCT model 
as a culturally and clinically effective service for diabetes 
management in Aboriginal Australia. This study also veriﬁ es 
that the role of POCT in achieving better clinical outcomes 
stems mainly from its convenience, the immediacy of result, 
and an enhanced doctor-patient relationship collectively 
leading to greater patient self-motivation.
In previously published material, the QAAMS Program has 
been shown to be analytically sound in Aboriginal hands, with 
the quality of POCT for both HbA
1c
 (and urine ACR) continuing 
to improve across time, meeting analytical performance goals 
and matching equivalent laboratory performance.
Reimbursement of POC HbA
1c
 and urine ACR tests 
conducted for diabetes management can be obtained through 
the Australian Government’s Medicare rebate system. This 
rebate system ensures that the QAAMS Program remains cost 
neutral for participants and is ﬁ nancially sustainable in the 
long term.
The QAAMS model has also shown its versatility in being 
adaptable to other health sectors in Australia. For the past 
three years, the Community Point-of-Care Services unit at 
Flinders University (from which QAAMS is now managed) 
have provided specialist POCT services for a novel program 
called Diabetes Management Along the Mallee Track, which 
is based at the remote town of Ouyen in north-west Victoria.15
In this program, POCT is provided through the local hospital 
and general practice as part of an integrated, multidisciplinary 
‘one-stop’, management service for diabetes patients across 
the region. POC HbA
1c
, urine ACR (and lipid) measurements 
are conducted by nursing staff who participate in on-going 
education and training sessions and conduct regular quality 
testing. This model has gained widespread acceptance by 
the Mallee Track community and also resulted in improved 
clinical outcomes for diabetes patients from the region. 
In summary, there is now a considerable evidence base to 
show the QAAMS POCT model for diabetes management 
in Aboriginal Australia is analytically sound, culturally and 
clinically effective (providing a convenient and accessible 
service for both doctors and patients with diabetes), results in 
improved clinical outcomes, is sustainable, and is adaptable 
and transferable to other POC tests and other non-Indigenous 
health settings in rural and remote Australia.
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